Michael J. Gaunt PharmD
Michael J. Gaunt, PharmD is a Medication Safety Analyst at the Institute for Safe Medication Practices. He co-coordinates the ISMP National Medication Errors Reporting Program (ISMP MERP) and the ISMP National Vaccine Errors Reporting Program (ISMP VERP). In this role, he works collaboratively with the US Food and Drug Administration (FDA) to advocate for nomenclature, packaging, and labeling improvements to reduce the risk of error. Michael also serves as the editor of the monthly ISMP Medication Safety Alert!® Community/Ambulatory Care Edition newsletter. He is a Senior Medication Safety Analyst for the Pennsylvania Patient Safety Authority and is responsible for reviewing and analyzing medication-related reports from hospitals, ambulatory surgical centers, and other facilities in Pennsylvania. Michael is also one of the project leaders for the Hospital and Healthsystem Association of Pennsylvania (HAP) Hospital Improvement Innovation Network’s (HIIN) Adverse Drug Event (ADE) Project. He has published articles in the patient safety and pharmacy literature, including the Pennsylvania Patient Safety Advisory and a monthly column in Pharmacy Times. Michael represents ISMP on the Centers for Disease Control and Prevention (CDC) PROTECT Initiative. He is also one of ISMP’s representatives on the National Coordinating Council for Medication Error Reporting and Prevention (NCC MERP). Michael’s healthcare experience includes patient care positions in behavioral health and community pharmacy. He received a Bachelor of Arts in History from the University of Notre Dame and a Doctor of Pharmacy with Certificates in Drug Safety from Temple University School of Pharmacy.